U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07496021) titled 'Safety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's Disease' on March 22.
Brief Summary: Randomized, Placebo-Controlled, Double-Blind, 24-Week Proof-of-Concept Study to Evaluate the Safety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's Disease
Study Start Date: Feb. 23
Study Type: INTERVENTIONAL
Condition:
Early Alzheimers Disease
Intervention:
DRUG: L. lactis CKDB001
Oral Capsule
DRUG: Placebo
Oral Capsule
Recruitment Status: RECRUITING
Sponsor: CKD Bio Corporation
Published by HT Digital Content Services with permission from Health Daily Digest....